
Aradhana Sasan
Examiner (ID: 10759, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 755 |
| Pending Applications | 112 |
| Abandoned Applications | 468 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19104696
[patent_doc_number] => 11957769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Polyhydroxy fullerene sunscreen active agents and compositions
[patent_app_type] => utility
[patent_app_number] => 17/182093
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10367
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182093
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182093 | Polyhydroxy fullerene sunscreen active agents and compositions | Feb 21, 2021 | Issued |
Array
(
[id] => 17235493
[patent_doc_number] => 11179356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Methods and compositions to modulate the gut microbiota and to manage weight
[patent_app_type] => utility
[patent_app_number] => 17/180256
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31720
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180256 | Methods and compositions to modulate the gut microbiota and to manage weight | Feb 18, 2021 | Issued |
Array
(
[id] => 19674458
[patent_doc_number] => 12186296
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-07
[patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
[patent_app_type] => utility
[patent_app_number] => 17/178117
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 147
[patent_no_of_words] => 96563
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178117
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178117 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Feb 16, 2021 | Issued |
Array
(
[id] => 16776433
[patent_doc_number] => 20210113510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/137713
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137713 | Stable pharmaceutical composition and methods of using same | Dec 29, 2020 | Issued |
Array
(
[id] => 18517210
[patent_doc_number] => 11707080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Infant formula with special lipid architecture for improving postnatal growth of infants born by Caesarean section
[patent_app_type] => utility
[patent_app_number] => 17/775889
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11060
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775889 | Infant formula with special lipid architecture for improving postnatal growth of infants born by Caesarean section | Dec 3, 2020 | Issued |
Array
(
[id] => 16718454
[patent_doc_number] => 20210085601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => CROMOLYN COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/108895
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/108895 | Cromolyn compositions and methods thereof | Nov 30, 2020 | Issued |
Array
(
[id] => 16883616
[patent_doc_number] => 20210169811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => CONTROLLED-RELEASE SYSTEM OF ACTIVE PHARMACEUTICAL INGREDIENT AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/101706
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/101706 | Controlled-release system of active pharmaceutical ingredient and preparation method therefor | Nov 22, 2020 | Issued |
Array
(
[id] => 16686856
[patent_doc_number] => 20210069331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => SCINTILLATOR NANOCRYSTAL-CONTAINING COMPOSITIONS AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/099663
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099663
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099663 | Scintillator nanocrystal-containing compositions and methods for their use | Nov 15, 2020 | Issued |
Array
(
[id] => 16791588
[patent_doc_number] => 20210121405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => Methods for Formulating an API, Composite Materials, and Solid Unit Dosage Forms
[patent_app_type] => utility
[patent_app_number] => 17/081512
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081512
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081512 | Methods for Formulating an API, Composite Materials, and Solid Unit Dosage Forms | Oct 26, 2020 | Abandoned |
Array
(
[id] => 18003433
[patent_doc_number] => 20220362199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/771173
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771173 | ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS | Oct 22, 2020 | Pending |
Array
(
[id] => 16791591
[patent_doc_number] => 20210121408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => Methods of Administering Cannabinoid to People Diagnosed With HIV
[patent_app_type] => utility
[patent_app_number] => 17/075656
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075656
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075656 | Methods of Administering Cannabinoid to People Diagnosed With HIV | Oct 19, 2020 | Abandoned |
Array
(
[id] => 16613923
[patent_doc_number] => 20210032576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => ANTI-VIRAL CLEANING COMPOSITION, METHOD OF MAKING AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/065981
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065981
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065981 | Anti-viral cleaning composition, method of making and use thereof | Oct 7, 2020 | Issued |
Array
(
[id] => 16655881
[patent_doc_number] => 20210052517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => EXTENDED RELEASE PHARMACEUTICAL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/030705
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/030705 | Extended release pharmaceutical formulation | Sep 23, 2020 | Issued |
Array
(
[id] => 16718466
[patent_doc_number] => 20210085613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => IBUDILAST ORAL FORMULATIONS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/027567
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027567
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/027567 | Ibudilast oral formulations and methods of using same | Sep 20, 2020 | Issued |
Array
(
[id] => 17561683
[patent_doc_number] => 20220125832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => USE OF PRUSSIAN BLUE NANOPARTICLES IN THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION, DELAY OR TREATMENT OF NEURODEGENERATIVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/257076
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257076
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257076 | USE OF PRUSSIAN BLUE NANOPARTICLES IN THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION, DELAY OR TREATMENT OF NEURODEGENERATIVE DISEASE | Sep 17, 2020 | Abandoned |
Array
(
[id] => 16555638
[patent_doc_number] => 20210000786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Taxane Particles and Their Use
[patent_app_type] => utility
[patent_app_number] => 17/023635
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/023635 | Taxane particles and their use | Sep 16, 2020 | Issued |
Array
(
[id] => 16539271
[patent_doc_number] => 20200405684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Taxane Particles and Their Use
[patent_app_type] => utility
[patent_app_number] => 17/023098
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/023098 | Taxane Particles and Their Use | Sep 15, 2020 | Abandoned |
Array
(
[id] => 19853960
[patent_doc_number] => 12256765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Hydrolyzed pea protein-based nutrient composition
[patent_app_type] => utility
[patent_app_number] => 17/021339
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8681
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021339 | Hydrolyzed pea protein-based nutrient composition | Sep 14, 2020 | Issued |
Array
(
[id] => 16539262
[patent_doc_number] => 20200405675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/016577
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016577 | Stable pharmaceutical composition and methods of using same | Sep 9, 2020 | Issued |
Array
(
[id] => 16726441
[patent_doc_number] => 20210093588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Bis-Choline Tetrathiomolybdate for Treating Wilson Disease
[patent_app_type] => utility
[patent_app_number] => 16/997928
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997928 | Bis-choline tetrathiomolybdate for treating Wilson Disease | Aug 18, 2020 | Issued |